ACRO originated from a group of scholars at the University of Taiwan with the founder Richard Chu, looking for the materials for disease treatment and health care from the traditional Chinese medicine and natural herbal medicine. First, to find the target from the rule of thumb in Chinese medicine usage and then validate and develop by science methods. The preferred material is China treasure, "Cordyceps".
The business model of ACRO is mainly to use the advanced core technology and materials to assist the marketing enterprises to develop competitive goods; ACRO also makes new drug development projects in the United States and Chinaand proposed development strategies to integrate the Chinese market innew situation, break through the risk of high cost and the long time. ACRO will operate two main axis - health food development and new drug development.